Publications - RTI Health Solutions

Publications

Full Publications List (1034 results)

Search Publications

Displaying 41 through 60 of 1034 items.

« Previous Page 1 2 3 4 5 6 7 8 9 10 20 30 40 50 52 Next » [Show All]

2009

Johannes, C.B., A.H. Clayton, D.M. Odom, R.C. Rosen, P.A. Russo, J.L. Shifren, and B.U. Monz. (2009). "Distressing Sexual Problems in United States Women Revisited: Prevalence After Accounting for Depression." Journal of Clinical Psychiatry, 70(12):1698-1706.

Marshall, D.A., F.R. Johnson, N.A. Kulin, S. Ozdemir, J.M.E. Walsh, J.K. Marshall, S. Van Bebber, and K.A. Phillips. (2009). "How do Physician Assessments of Patient Preferences for Colorectal Cancer Screening Tests Differ from Actual Preferences? A Comparison in Canada and the United States Using A Stated-Choice Survey." Health Economics, 18(12):1420-1439.

Background: Patient preferences can affect colorectal cancer (CRC) screening test use. We compared utility-based preferences for alternative CRC screening tests from a stated-preference... Full Abstract »

Spiegel, B., M. Camilleri, R. Bolus, V. Andresen, W.D. Chey, S. Fehnel, A. Mangel, N.J. Talley, and W.E. Whitehead. (2009). "Psychometric Evaluation of Patient-Reported Outcomes in Irritable Bowel Syndrome Randomized Controlled Trials: A Rome Foundation Report." Gastroenterology, 137(6):1944-1953.

Castellsague, J., C.N. Holick, C.C. Hoffman, V. Gimeno, M.R. Stang, and S. Perez-Gutthann. (2009). "Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs." Pharmacotherapy, 29(12):1397-1407.

STUDY OBJECTIVE: To estimate the risk of upper gastrointestinal complications associated with use of cyclooxygenase-2 (COX-2) selective (celecoxib and rofecoxib) and individual nonselective... Full Abstract »

Mangel, A.W.. (2009). "The FDA and IBS Drug Development." American Journal of Gastroenterology, 104(12):3106-3106.

Van Houtven, G., and C. Poulos. (2009). "Valuing Welfare Impacts of Beach Erosion: An Application of the Structural Benefit Transfer Method." American Journal of Agricultural Economics, 91(5):1343-1350.

Mast, T.C., X.S. Zhu, C. Demuro-Mercon, H.W. Cummings, H.L. Sings, and D.G. Ferris. (2009). "Development and psychometric properties of the HPV Impact Profile (HIP) to assess the psychosocial burden of HPV." Current Medical Research and Opinion, 25(11):2609-2619.

Fehnel, S.. (2009). "Establishing Optimal Requirements for Content Validity: A Work in Progress." Value in Health, 12(8):1074-1074.

Talbird, S.E., A.J. Brogan, and A.P. Winiarski. (2009). "Oseltamivir for influenza postexposure prophylaxis: economic evaluation for children aged 1-12 years in the U.S." American Journal of Preventive Medicine, 37(5):381-388.

BACKGROUND: Postexposure prophylaxis (PEP) with oseltamivir (Tamiflu) has been shown to be effective and is approved in children exposed to a case of influenza in a household setting. Given limited... Full Abstract »

Talbird, S.E., A.J. Brogan, and A.P. Winiarski. (2009). "Oseltamivir for influenza postexposure prophylaxis: economic evaluation for children aged 1-12 years in the U.S.." American Journal of Preventive Medicine, 37(5):381-388.

BACKGROUND: Postexposure prophylaxis (PEP) with oseltamivir (Tamiflu) has been shown to be effective and is approved in children exposed to a case of influenza in a household setting. Given limited... Full Abstract »

Juniper, M., T.K. Le, and D. Mladsi. (2009). "The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review." Expert Opinion on Pharmacotherapy, 10(16):2581-2592.

Objective: This study's objective was to review the literature on the epidemiological and economic burden and treatment of chronic low back pain (CLBP) in France, Germany, Italy, Spain and the UK.... Full Abstract »

Ehrenstein, V., K.J. Rothman, L. Pedersen, E.E. Hatch, and H.T. Sorensen. (2009). "Pregnancy-associated Hypertensive Disorders and Adult Cognitive Function Among Danish Conscripts." American Journal of Epidemiology, 170(8):1025-1031.

Starke, J.R., L. Mucci, K.J. Rothman, and H.O. Adami. (2009). "Screening for prostate cancer remains controversial." BMJ, 339(7724):b3601-.

The introduction of prostate specific antigen (PSA) testing as a screening tool has transformed the clinical landscape of prostate cancer. Screening allows prostate cancer to be diagnosed many years... Full Abstract »

Mintz, M., A.W. Gilsenan, C.L. Bui, R. Ziemiecki, R.H. Stanford, W. Lincourt, and H. Ortega. (2009). "Assessment of asthma control in primary care." Current Medical Research and Opinion, 25(10):2523-2531.

Choy, E.H., L.M. Arnold, D.J. Clauw, L.J. Crofford, J.M. Glass, L.S. Simon, S.A. Martin, C.V. Strand, D.A. Williams, and P.J. Mease. (2009). "Content and Criterion Validity of the Preliminary Core Dataset for Clinical Trials in Fibromyalgia Syndrome." Journal of Rheumatology, 36(10):2330-2334.

Mease, P., L.M. Arnold, E.H. Choy, D.J. Clauw, L.J. Crofford, J.M. Glass, S.A. Martin, J. Morea, L. Simon, C.V. Strand, and D.A. Williams. (2009). "Fibromyalgia Syndrome Module at OMERACT 9: Domain Construct." Journal of Rheumatology, 36(10):2318-2329.

Zhou, X.L., D. Cella, D. Cameron, M.M. Amonkar, A. Segreti, S. Stein, M. Walker, and C.E. Geyer. (2009). "Lapatinib plus capecitabine versus capecitabine alone for HER2+(ErbB2+) metastatic breast cancer: quality-of-life assessment." Breast Cancer Research and Treatment, 117(3):577-589.

Carson, R., V. Williams, L. Nelson, J. MacDougall, and J. Johnston. (2009). "Psychometric Evaluation of Patient-Reported Outcome Measures for Assessing IBS-C Symptom Severity and Global Change: Results From a Phase 2b Study of Linaclotide." American Journal of Gastroenterology, 104:1113-.

Johnson, F.R., A.B. Hauber, and C.M. Poulos. (2009). "A brief introduction to the use of stated-choice methods to measure preferences for treatment benefits and risks." In RTI Press Publication No. RR-0009-0909.

Regulatory decisions to approve, restrict development, or halt the marketing of new pharmaceuticals require evaluating the balance between benefits and risks, given the available evidence at a point... Full Abstract »

Jeuland, M., J. Cook, C. Poulos, J. Clemens, and D. Whittington. (2009). "Cost-effectiveness of new-generation oral cholera vaccines: A multisite analysis." Value in Health, 12(6):899-908.

Objectives: We evaluated the cost-effectiveness of a low-cost cholera vaccine licensed and used in Vietnam, using recently collected data from four developing countries where cholera is endemic. Our... Full Abstract »

Displaying 41 through 60 of 1034 items.

« Previous Page 1 2 3 4 5 6 7 8 9 10 20 30 40 50 52 Next » [Show All]